Topic: Product Liability Cases
An $8 billion jury verdict against Johnson & Johnson raised eyebrows back in October, but the judge has now slashed damages to just $6.8 million.
Merck & Co.'s Fosamax fight has lasted for years—and now, thanks to a U.S. Supreme Court ruling Monday, Merck gets yet another chance to press its case.
As the FDA works to contain the damage from a massive recall of blood pressure drugs, litigation stemming from the mess is just getting started.
Bayer and J&J agreed to pay $775 million to wrap up about 25,000 lawsuits claiming their Xarelto anticoagulant caused severe bleeding.
The U.S. is supporting Merck in the Fosamax case, which addresses the question of whether FDA decisions shield pharma from state suits.
A judge decided a $140 million AndroGel verdict against AbbVie was inconsistent and ordered a new trial in the fall.
The U.S. Supreme Court will hear Merck's appeal in a long-running Fosamax liability fight, a move that could ripple through the pharma industry.
Merck's ruling at the Supreme Court could affect liability lawsuits across Big Pharma.
A South Carolina lawsuit alleging a link between Johnson & Johnson's baby powder and mesothelioma ended in a mistrial.
In response to the Supreme Court’s request to weigh in, the Solicitor General sided with Merck, saying that preemption should be determined by a judge, not a jury.